Kadence Blocks Page Builder Toolkit for Gutenberg Editor Plugin up to 3.5.32 on WordPress authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in Kadence Blocks Page Builder Toolkit for Gutenberg Editor Plugin up to 3.5.32 on WordPress. This vulnerability affects unknown code. Such manipulation leads to authorization. This vulnerability is referenced as CVE-2026-2608. It is possible to launch the attack remotely. No exploit is available.
Details
A vulnerability, which was classified as critical, has been found in Kadence Blocks Page Builder Toolkit for Gutenberg Editor Plugin up to 3.5.32 on WordPress. Affected by this issue is some unknown functionality. The manipulation with an unknown input leads to a authorization vulnerability. Using CWE to declare the problem leads to CWE-862. The product does not perform an authorization check when an actor attempts to access a resource or perform an action. Impacted is confidentiality, integrity, and availability. CVE summarizes:
The Kadence Blocks — Page Builder Toolkit for Gutenberg Editor plugin for WordPress is vulnerable to unauthorized access due to a missing capability check on a function in all versions up to, and including, 3.5.32. This makes it possible for authenticated attackers, with Contributor-level access and above, to perform an unauthorized action.
The advisory is available at wordfence.com. This vulnerability is handled as CVE-2026-2608. The exploitation is known to be easy. The attack may be launched remotely. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 02/20/2026).
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
- 3.5.0
- 3.5.1
- 3.5.2
- 3.5.3
- 3.5.4
- 3.5.5
- 3.5.6
- 3.5.7
- 3.5.8
- 3.5.9
- 3.5.10
- 3.5.11
- 3.5.12
- 3.5.13
- 3.5.14
- 3.5.15
- 3.5.16
- 3.5.17
- 3.5.18
- 3.5.19
- 3.5.20
- 3.5.21
- 3.5.22
- 3.5.23
- 3.5.24
- 3.5.25
- 3.5.26
- 3.5.27
- 3.5.28
- 3.5.29
- 3.5.30
- 3.5.31
- 3.5.32
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.2
VulDB Base Score: 6.3
VulDB Temp Score: 6.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 4.3
CNA Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: AuthorizationCWE: CWE-862 / CWE-863 / CWE-285
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
02/17/2026 Advisory disclosed02/17/2026 VulDB entry created
02/20/2026 VulDB entry last update
Sources
Advisory: wordfence.comStatus: Not defined
CVE: CVE-2026-2608 (🔒)
GCVE (CVE): GCVE-0-2026-2608
GCVE (VulDB): GCVE-100-346250
Entry
Created: 02/17/2026 03:47Updated: 02/20/2026 13:51
Changes: 02/17/2026 03:47 (50), 02/17/2026 13:56 (12), 02/20/2026 13:51 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.